D

DMIIR

Financials

Drugs Made In America Acquisition II Corp Right

$0.09+0.01 (+5.56%)PRE

Live · NASDAQ · May 9, Close

AI Insight

What's Moving DMIIR Today?

No stock-specific AI insight has been generated for DMIIR yet. Check back soon — insights are generated from recent news analysis.

52-Week Range

$0.06$0.17

$0.09

Fundamentals

Market Cap
P/E Ratio
EPS
Dividend Yield
Dividend / Share
ROE
Profit Margin
Debt / Equity

Trading

Volume78K
Avg Volume (10D)
Shares Outstanding

Price Data

Open$0.00
Previous Close$0.09
Day High$0.00
Day Low$0.00
52 Week High$0.17
52 Week Low$0.06

About Drugs Made In America Acquisition II Corp Right

Drugs Made In America Acquisition II Corp. Right (DMIIR) is a special purpose acquisition company focused on identifying and merging with innovative companies in the pharmaceutical sector to enhance domestic drug manufacturing. With a seasoned management team possessing extensive industry experience, DMIIR aims to capitalize on the increasing demand for accessible, affordable, and sustainable U.S.-produced medicines. By pursuing transformative opportunities within this sector, DMIIR not only seeks to generate significant shareholder value but also contributes to the development of vital infrastructure in the American healthcare landscape.

FinancialsBLANK CHECKS

Company Details

Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot
SICBLANK CHECKS
CIK
Composite FIGI
Share Class FIGI